CH3 BioSystems, LLC

CH3 BioSystems is pleased to provide our customers with an expanded product line featuring novel molecular reagents and cancer cell lines for research purposes in cellular and molecular protein methylation studies.

THE SURVIVIN GENE PROMOTER IS A PRIME TARGET FOR TRANSCRIPTIONAL REGULATION VIA PROTEIN ARGININE METHYLATION

Recent studies (Du et al., 2011) emphasize the importance of protein arginine methylation for regulating gene transcription activated via the survivin promoter. CH3 BioSystems now offers an extensive list of vectors and additional ancillary tools to help with the molecular dissection of this phenomenon.

We have also added more cell lines to support your cellular and molecular studies in intact biological systems. Please visit the CELL LINES for more information.

Get the latest news in protein methylation research & CH3 BioSystems. more

New Product!
UNIQUE High Activity PRMT7, Type III
Methyltransferase
NOW AVAILABLE
ONLY from
CH3 BioSystems

CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates.

We manufacture novel molecular tools to help biomedical research better understand cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.

Our long-range vision is to facilitate the creation of diagnostic and pharmaceutical products that are based on the emerging new field of protein methylation biology.

Follow @CH3Bio